William Chapman

3.1k total citations
65 papers, 2.4k citations indexed

About

William Chapman is a scholar working on Epidemiology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, William Chapman has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 18 papers in Obstetrics and Gynecology and 17 papers in Surgery. Recurrent topics in William Chapman's work include Endometrial and Cervical Cancer Treatments (18 papers), Cervical Cancer and HPV Research (18 papers) and Ovarian cancer diagnosis and treatment (15 papers). William Chapman is often cited by papers focused on Endometrial and Cervical Cancer Treatments (18 papers), Cervical Cancer and HPV Research (18 papers) and Ovarian cancer diagnosis and treatment (15 papers). William Chapman collaborates with scholars based in Canada, United States and New Zealand. William Chapman's co-authors include David J. Nesbitt, Ming‐Sound Tsao, Alice Lytwyn, Vuk Stambolic, Tak W. Mak, Akira Suzuki, Bharati Bapat, James B. Mahony, David MacPherson and Marie Sano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Chemical Physics and Cancer.

In The Last Decade

William Chapman

63 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Chapman Canada 27 777 757 579 524 415 65 2.4k
Joseph W. Carlson United States 37 1.3k 1.6× 382 0.5× 273 0.5× 794 1.5× 1.5k 3.5× 131 4.5k
K. Stelzer United States 28 161 0.2× 588 0.8× 378 0.7× 332 0.6× 235 0.6× 94 2.6k
David M. King United Kingdom 25 360 0.5× 150 0.2× 222 0.4× 318 0.6× 133 0.3× 45 3.0k
Riccardo Rosso Italy 29 379 0.5× 158 0.2× 340 0.6× 1.2k 2.3× 130 0.3× 135 2.5k
Shahid M. Hussain Netherlands 32 348 0.4× 851 1.1× 1.4k 2.5× 465 0.9× 99 0.2× 107 4.4k
Gad Singer Switzerland 28 1.0k 1.3× 187 0.2× 407 0.7× 900 1.7× 416 1.0× 106 3.7k
Rachel Cooper United Kingdom 27 370 0.5× 141 0.2× 519 0.9× 463 0.9× 363 0.9× 81 2.6k
Melanie Powell United Kingdom 26 283 0.4× 265 0.4× 373 0.6× 353 0.7× 1.2k 2.8× 59 2.2k
Atsushi Manabe Japan 34 1.2k 1.5× 190 0.3× 265 0.5× 698 1.3× 142 0.3× 262 4.8k
Olav Kaalhus Norway 34 869 1.1× 141 0.2× 995 1.7× 651 1.2× 76 0.2× 114 3.3k

Countries citing papers authored by William Chapman

Since Specialization
Citations

This map shows the geographic impact of William Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Chapman more than expected).

Fields of papers citing papers by William Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Chapman. The network helps show where William Chapman may publish in the future.

Co-authorship network of co-authors of William Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of William Chapman. A scholar is included among the top collaborators of William Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Chapman. William Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
McCarthy, Aoife J, Marjan Rouzbahman, S. A. Thiryayi, William Chapman, & Blaise Clarke. (2019). Neoadjuvant therapy in gynaecological malignancies: What pathologists need to know. Journal of Clinical Pathology. 72(2). 102–111. 2 indexed citations
3.
Bouchard‐Fortier, Geneviève, Tony Panzarella, Barry P. Rosen, William Chapman, & Lilian T. Gien. (2016). Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up. Journal of Obstetrics and Gynaecology Canada. 39(1). 34–41. 20 indexed citations
4.
Ceballos, Kathy, William Chapman, Dean Daya, et al.. (2008). Reproducibility of the Histological Diagnosis of Cervical Dysplasia Among Pathologists From 4 Continents. International Journal of Gynecological Pathology. 27(1). 101–107. 15 indexed citations
5.
Lytwyn, Alice, Irving E. Salit, Janet Raboud, et al.. (2005). Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer. 103(7). 1447–1456. 102 indexed citations
6.
Geddie, William R., et al.. (2005). Characteristics of Apparently False-Negative Digene Hybrid Capture 2 High-Risk HPV DNA Testing. American Journal of Clinical Pathology. 125(2). 223–228. 34 indexed citations
7.
Hwang, David, Gordon M. Lickrish, William Chapman, & Terence J. Colgan. (2004). Long-Term Surveillance Is Required for All Women Treated for Cervical Adenocarcinoma In Situ. Journal of Lower Genital Tract Disease. 8(2). 125–131. 14 indexed citations
8.
Steed, Helen, William Chapman, & Stéphane Laframboise. (2004). Endometriosis-Associated Ovarian Cancer: A Clinicopathologic Review. Journal of Obstetrics and Gynaecology Canada. 26(8). 709–715. 21 indexed citations
9.
Grisaru, Dan, Allan Covens, Edmée Franssen, et al.. (2003). Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2–IB1–2 cervical carcinoma. Cancer. 97(8). 1904–1908. 43 indexed citations
10.
Latta, Eleanor & William Chapman. (2002). PTEN mutations and evolving concepts in endometrial neoplasia. Current Opinion in Obstetrics & Gynecology. 14(1). 59–65. 50 indexed citations
11.
Chapman, William, et al.. (2002). Considerations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene. American Journal Of Pathology. 160(3). 795–800. 91 indexed citations
12.
13.
Chapman, William. (2001). Developments in the pathology of ovarian tumours. Current Opinion in Obstetrics & Gynecology. 13(1). 53–59. 14 indexed citations
14.
Fong, Katherine, Rose Kung, Alice Lytwyn, et al.. (2001). Endometrial Evaluation with Transvaginal US and Hysterosonography in Asymptomatic Postmenopausal Women with Breast Cancer Receiving Tamoxifen. Radiology. 220(3). 765–773. 33 indexed citations
15.
Tsang, Richard, Anthony Fyles, Yuqing Li, et al.. (1999). Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Radiotherapy and Oncology. 50(1). 85–92. 21 indexed citations
16.
Levin, Wilfred, et al.. (1999). Radiotherapy for the Treatment of Metastatic Granulosa Cell Tumor in the Mediastinum: A Case Report. Gynecologic Oncology. 73(3). 455–460. 17 indexed citations
17.
Wong, C. Shun, et al.. (1999). Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. International Journal of Radiation Oncology*Biology*Physics. 45(2). 309–314. 30 indexed citations
18.
Tsang, Richard, C. Shun Wong, Anthony Fyles, et al.. (1999). Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. Radiotherapy and Oncology. 50(1). 93–101. 40 indexed citations
19.
Goldberg, Zelanna, Bernard Cummings, William Chapman, Henry J. Klamut, & Andrew M. Rauth. (1998). Role of a DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil, and mitomycin C. International Journal of Radiation Oncology*Biology*Physics. 42(2). 331–334. 4 indexed citations
20.
Nozawa, Shiro, et al.. (1990). MSN-1 Antibody in the Evaluation of Female Genital Tract Adenocarcinomas. International Journal of Gynecological Pathology. 9(1). 73–79. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph W. Carlson Breakdown of academic impact, for papers by K. Stelzer Breakdown of academic impact, for papers by David M. King Breakdown of academic impact, for papers by Riccardo Rosso Breakdown of academic impact, for papers by Shahid M. Hussain Breakdown of academic impact, for papers by Gad Singer Breakdown of academic impact, for papers by Rachel Cooper Breakdown of academic impact, for papers by Melanie Powell Breakdown of academic impact, for papers by Atsushi Manabe Breakdown of academic impact, for papers by Olav Kaalhus
Rankless by CCL
2026